121 related articles for article (PubMed ID: 19796211)
1. Inhaled vs subcutaneous effects of a dual IL-4/IL-13 antagonist in a monkey model of asthma.
Tomkinson A; Tepper J; Morton M; Bowden A; Stevens L; Harris P; Lindell D; Fitch N; Gundel R; Getz EB
Allergy; 2010 Jan; 65(1):69-77. PubMed ID: 19796211
[TBL] [Abstract][Full Text] [Related]
2. Pitrakinra for asthma.
Antoniu SA; Cojocaru I
Expert Opin Biol Ther; 2010 Nov; 10(11):1609-15. PubMed ID: 20923253
[TBL] [Abstract][Full Text] [Related]
3. Human pharmacokinetics/pharmacodynamics of an interleukin-4 and interleukin-13 dual antagonist in asthma.
Burmeister Getz E; Fisher DM; Fuller R
J Clin Pharmacol; 2009 Sep; 49(9):1025-36. PubMed ID: 19717725
[TBL] [Abstract][Full Text] [Related]
4. Effect of an orally active Th1/Th2 balance modulator, M50367, on IgE production, eosinophilia, and airway hyperresponsiveness in mice.
Kato Y; Manabe T; Tanaka Y; Mochizuki H
J Immunol; 1999 Jun; 162(12):7470-9. PubMed ID: 10358202
[TBL] [Abstract][Full Text] [Related]
5. 4-1 BB stimulation inhibits allergen-specific immunoglobulin E production and airway hyper-reactivity but partially suppresses bronchial eosinophilic inflammation in a mouse asthma model.
Cho YS; Kwon B; Lee TH; Kim TB; Moon KA; La S; Lee J; Lee SD; Oh YM; Moon HB
Clin Exp Allergy; 2006 Mar; 36(3):377-85. PubMed ID: 16499650
[TBL] [Abstract][Full Text] [Related]
6. [Protective effects of ketamine on allergen-induced airway inflammatory injure and high airway reactivity in asthma: experiment with rats].
Zhu MM; Qian YN; Zhu W; Xu YM; Rong HB; Ding ZN; Fu CZ
Zhonghua Yi Xue Za Zhi; 2007 May; 87(19):1308-13. PubMed ID: 17727773
[TBL] [Abstract][Full Text] [Related]
7. Preclinical efficacy and safety of mepolizumab (SB-240563), a humanized monoclonal antibody to IL-5, in cynomolgus monkeys.
Hart TK; Cook RM; Zia-Amirhosseini P; Minthorn E; Sellers TS; Maleeff BE; Eustis S; Schwartz LW; Tsui P; Appelbaum ER; Martin EC; Bugelski PJ; Herzyk DJ
J Allergy Clin Immunol; 2001 Aug; 108(2):250-7. PubMed ID: 11496242
[TBL] [Abstract][Full Text] [Related]
8. IL-4 induces IL-13-independent allergic airway inflammation.
Perkins C; Wills-Karp M; Finkelman FD
J Allergy Clin Immunol; 2006 Aug; 118(2):410-9. PubMed ID: 16890766
[TBL] [Abstract][Full Text] [Related]
9. Effect of an interleukin-4 variant on late phase asthmatic response to allergen challenge in asthmatic patients: results of two phase 2a studies.
Wenzel S; Wilbraham D; Fuller R; Getz EB; Longphre M
Lancet; 2007 Oct; 370(9596):1422-31. PubMed ID: 17950857
[TBL] [Abstract][Full Text] [Related]
10. Mepacrine alleviates airway hyperresponsiveness and airway inflammation in a mouse model of asthma.
Ram A; Mabalirajan U; Singh SK; Singh VP; Ghosh B
Int Immunopharmacol; 2008 Jun; 8(6):893-9. PubMed ID: 18442795
[TBL] [Abstract][Full Text] [Related]
11. Fritillaria cirrhosa, Anemarrhena asphodeloides, Lee-Mo-Tang and cyclosporine a inhibit ovalbumin-induced eosinophil accumulation and Th2-mediated bronchial hyperresponsiveness in a murine model of asthma.
Yeum HS; Lee YC; Kim SH; Roh SS; Lee JC; Seo YB
Basic Clin Pharmacol Toxicol; 2007 Mar; 100(3):205-13. PubMed ID: 17309526
[TBL] [Abstract][Full Text] [Related]
12. IL-13 blockade reduces lung inflammation after Ascaris suum challenge in cynomolgus monkeys.
Bree A; Schlerman FJ; Wadanoli M; Tchistiakova L; Marquette K; Tan XY; Jacobson BA; Widom A; Cook TA; Wood N; Vunnum S; Krykbaev R; Xu X; Donaldson DD; Goldman SJ; Sypek J; Kasaian MT
J Allergy Clin Immunol; 2007 May; 119(5):1251-7. PubMed ID: 17379289
[TBL] [Abstract][Full Text] [Related]
13. Effects of ciclamilast, a new PDE 4 PDE4 inhibitor, on airway hyperresponsiveness, PDE4D expression and airway inflammation in a murine model of asthma.
Deng YM; Xie QM; Tang HF; Sun JG; Deng JF; Chen JQ; Yang SY
Eur J Pharmacol; 2006 Oct; 547(1-3):125-35. PubMed ID: 16956605
[TBL] [Abstract][Full Text] [Related]
14. Modulation of airway hyperresponsiveness and eosinophilia by selective histamine and 5-HT receptor antagonists in a mouse model of allergic asthma.
De Bie JJ; Henricks PA; Cruikshank WW; Hofman G; Jonker EH; Nijkamp FP; Van Oosterhout AJ
Br J Pharmacol; 1998 Jul; 124(5):857-64. PubMed ID: 9692769
[TBL] [Abstract][Full Text] [Related]
15. Respiratory syncytial virus-induced airway hyperresponsiveness is independent of IL-13 compared with that induced by allergen.
Park JW; Taube C; Yang ES; Joetham A; Balhorn A; Takeda K; Miyahara N; Dakhama A; Donaldson DD; Gelfand EW
J Allergy Clin Immunol; 2003 Dec; 112(6):1078-87. PubMed ID: 14657862
[TBL] [Abstract][Full Text] [Related]
16. Differential effects of (S)- and (R)-enantiomers of albuterol in a mouse asthma model.
Henderson WR; Banerjee ER; Chi EY
J Allergy Clin Immunol; 2005 Aug; 116(2):332-40. PubMed ID: 16083788
[TBL] [Abstract][Full Text] [Related]
17. The effects of inhaled KP-496, a novel dual antagonist for cysteinyl leukotriene receptor and thromboxane A(2) receptor, on allergic asthmatic responses in guinea pigs.
Suda M; Okuda T; Ishimura M; Kurokawa S; Tokuoka S; Nakamura T; Takahashi Y; Tanaka H; Nagai H
Pharmacology; 2009; 84(4):249-56. PubMed ID: 19776661
[TBL] [Abstract][Full Text] [Related]
18. Inhaled carbenoxolone prevents allergic airway inflammation and airway hyperreactivity in a mouse model of asthma.
Ram A; Singh SK; Singh VP; Kumar S; Ghosh B
Int Arch Allergy Immunol; 2009; 149(1):38-46. PubMed ID: 19033731
[TBL] [Abstract][Full Text] [Related]
19. [The long term effect of small dose budesonide turbuhaler on mild bronchial asthma].
Weng JL; Zheng YS; Ma QF
Zhonghua Jie He He Hu Xi Za Zhi; 2005 Feb; 28(2):88-92. PubMed ID: 15854388
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic effect of intratracheal administration of murine IL-4 receptor antagonist on asthmatic airway inflammation.
Tian D; Fu Z; Liu E; He Y; Wang X; Wang L
J Asthma; 2008 Oct; 45(8):715-21. PubMed ID: 18951266
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
